MFUSE
Uncontrolled Post-Traumatic Hemorrhage
Pre-clinicalActive
Key Facts
About Machina Medical
Machina Medical is a private, pre-revenue medical device company focused on addressing uncontrolled post-traumatic hemorrhage, a leading cause of preventable death in both military and civilian settings. The company's core innovation is the MFUSE technology, a next-generation hemostatic wound care solution designed for use by military personnel, first responders, and in trauma centers. Operating in the stagnant hemostatic agent market, Machina aims to challenge decades-old foundational science with a novel approach, positioning itself to capture significant share in a large and critical global market.
View full company profile